Analyst Thinks Johnson & Johnson Could Hit a $280 Target
A major analyst raises the price target on Johnson & Johnson to $280, arguing growing oncology sales and a planned sp...
Learn about the wealth building strategies employed by the rich and how you can implement them in your life. Start your transformation now!
18,336 articlesA major analyst raises the price target on Johnson & Johnson to $280, arguing growing oncology sales and a planned sp...
XRP has surged past BNB to claim the fourth-largest spot by market capitalization as Ripple unveils a Brazil expansio...
Gold tumbles after the Federal Reserve narrows its rate-cut outlook, sliding from the $5,000 zone to around $4,500. T...
Hess Midstream’s capital return program is under review as a $60 million buyback coincides with a high payout ratio a...
Gas prices have moved sharply, with a $0.48 jump in one week. This article breaks down the reasons behind the move, w...
Japan sees renewed toilet paper stockpiling as global oil-market jitters ripple through households. Officials urge ca...
Tether, the issuer of the USDT stablecoin, has hired a Big Four firm to perform its first comprehensive audit, aiming...
DraftKings stock slides as a Senate measure targets prediction markets, while Penn Entertainment holds steady amid re...
Investors are weighing the beads-and-blood-screening company Cytosorbents as it reports 2025 earnings. This guide bre...
CoStar expands its copyright lawsuit against Zillow, alleging more than 53,000 watermarked photos are used across lis...
United Wholesale Mortgage announces a free 1-0 temporary rate buydown on purchase loans and introduces a new home equ...
A deep-dive look at electroCore's 2026 earnings narrative. This article unpacks Q1 signals, growth drivers, and pract...